Rivastigmine transdermal patch 13.3 mg/24 h: a review of its use in the management of mild to moderate Alzheimer's dementia. [electronic resource]
Producer: 20150309Description: 639-49 p. digitalISSN:- 1179-1969
- Alzheimer Disease -- drug therapy
- Cholinesterase Inhibitors -- administration & dosage
- Humans
- Neuroprotective Agents -- administration & dosage
- Phenylcarbamates -- administration & dosage
- Randomized Controlled Trials as Topic
- Rivastigmine
- Severity of Illness Index
- Transdermal Patch
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.